Translational Pharmacology Core – Center for AIDS Research

People | UR CFAR 

AIDS Research

CFAR at University of Rochester Medical Center

TPRC and the CFAR

Director: Gene D. Morse, PharmD

The Translational Pharmacology Core (TPC) is a multifaceted resource that facilitates clinical and translational pharmacology research among CFAR investigators. The TPC has been conducting antiretroviral pharmacology research since the beginning of the HIV epidemic and was one of the initial Pharmacology Specialty Laboratories funded at the University of Rochester Clinical Trials Unit when the AIDS Clinical Trials Group (ACTG) was established. The Core Director, Gene D. Morse, is a Board Certified Pharmacotherapy Specialist and directs this New York State-approved pharmacology laboratory. The TPC is a training site for numerous national and international faculty, pre-doctoral students, post-doctoral fellows and residents. Dr. Morse is the current Director of the ACTG Core Pharmacology Laboratory network and is a member of the Hepatitis Committee and ACTG Executive Committees. The TPC is a recognized international leader in HIV Clinical Pharmacology research and training and currently receives NIH funding for the NIAID HIV Clinical Pharmacology Quality Assurance Program, an AIDS Clinical Trials Group Pharmacology Specialty Laboratory and an AIDS International Training and Research Program in Clinical Pharmacology in Zimbabwe from the NIH Fogarty International Center. The TPC provides services to CFAR investigators that include: pre-clinical and clinical study design and analysis for pharmacokinetics, pharmacodynamics and pharmacogenomics as well as drug assays, drug interactions, therapeutic drug monitoring and nanopharmacology research.